Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER

  • Read more about HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER
US Application 61/549,862
Filed on 2011-10-21

The Ability Of Novel Yeast-MUC1 Constructs To Mature Human Dendritic Cells (DCs) And Activate Human T Cells

  • Read more about The Ability Of Novel Yeast-MUC1 Constructs To Mature Human Dendritic Cells (DCs) And Activate Human T Cells
US Application 61/524,407
Filed on 2011-08-17

Cross Reactive Antibodies Against Dengue Virus And Uses Thereof

  • Read more about Cross Reactive Antibodies Against Dengue Virus And Uses Thereof
US Application 61/646,638
Filed on 2012-05-14

Antibodies To Tumor Endothelial Marker 8

  • Read more about Antibodies To Tumor Endothelial Marker 8
US Application 61/527,339
Filed on 2011-08-25

Use Of MiRNA126 To Produce Hemapoietic Stem Cells

  • Read more about Use Of MiRNA126 To Produce Hemapoietic Stem Cells
US Application 61/542,468
Filed on 2011-10-03

T CELL RECEPTORS RECOGNIZING HLA-A1-OR HLA-CW7-RESTRICTED MAGE

  • Read more about T CELL RECEPTORS RECOGNIZING HLA-A1-OR HLA-CW7-RESTRICTED MAGE
US Application 61/535,086
Filed on 2011-09-15

PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC B CELL EPITOPES

  • Read more about PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC B CELL EPITOPES
US Application 61/535,668
Filed on 2011-09-16

Thioxothiazolidinone Derivatives Useful As Inhibitors Of Tdp1

  • Read more about Thioxothiazolidinone Derivatives Useful As Inhibitors Of Tdp1
US Application 61/545,308
Filed on 2011-10-10

Monospecific And Bispecific Human Monoclonal Antibodies Targeting Insulin-Like Growth Factor II (IGF-II)

  • Read more about Monospecific And Bispecific Human Monoclonal Antibodies Targeting Insulin-Like Growth Factor II (IGF-II)
US Application 61/548,164
Filed on 2011-10-17

Gene Expression Predictors of Tumor Responsiveness To Therapy

  • Read more about Gene Expression Predictors of Tumor Responsiveness To Therapy
US Application 61/525,539
Filed on 2011-08-19

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 108
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • Page 113
  • Page 114
  • Page 115
  • Page 116
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health